Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients
- PMID: 19487253
- DOI: 10.1124/dmd.109.027367
Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients
Abstract
Inflammatory bowel disease (IBD) is an inflammatory condition that affects the gastrointestinal tract. The solute carrier (SLC) superfamily of transporters comprise proteins involved in the uptake of drugs, hormones, and other biologically active compounds. The purpose of this study was to determine the mRNA expression levels of 15 solute carrier transporters in two regions of the intestine in IBD patients. Endoscopic biopsy specimens were taken from two locations (terminal ileum and colon) for histological examination and RNA extraction. We quantitatively measured the mRNA expression of 15 SLC transporters in 107 IBD patients (53 with Crohn's disease and 54 with ulcerative colitis) and 23 control subjects. mRNA expression was evaluated using the quantitative reverse transcription-polymerase chain reaction technique. We observed that in the ileum of IBD patients, mRNA levels for serotonin transporter, equilibrative nucleoside transporter (ENT) 1, ENT2, and organic anion-transporting polypeptide (OATP) 2B1 were significantly elevated, whereas levels for apical sodium-dependent bile acid transporter (ASBT) and organic zwitterion/cation transporter (OCTN) 2 were significantly lower. In colon, mRNA levels for ENT1, ENT2, concentrative nucleoside transporter (CNT) 2, OATP2B1, and OATP4A1 were significantly higher, whereas mRNA levels for OCTN2 were significantly decreased. In inflamed colon of IBD patients the mRNA expression levels of ENT1, ENT2, CNT2, OATP2B1, OATP4A1, and peptide transporter 1 were significantly higher. We conclude that intestinal SLC mRNA levels are dysregulated in IBD patients, which may be linked to the inflammation of the tissue and provides an indication about the role of inflammatory signaling in regulation of SLC expression.
Similar articles
-
Inflammatory bowel disease alters intestinal bile acid transporter expression.Drug Metab Dispos. 2014 Sep;42(9):1423-31. doi: 10.1124/dmd.114.058065. Epub 2014 Jun 25. Drug Metab Dispos. 2014. PMID: 24965812
-
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.Endoscopy. 2009 Jul;41(7):618-37. doi: 10.1055/s-0029-1214790. Epub 2009 Jul 8. Endoscopy. 2009. PMID: 19588292 Review.
-
Defensins and inflammation: the role of defensins in inflammatory bowel disease.J Gastroenterol Hepatol. 2009 Feb;24(2):202-8. doi: 10.1111/j.1440-1746.2008.05772.x. J Gastroenterol Hepatol. 2009. PMID: 19215333 Review.
-
Regional distribution of solute carrier mRNA expression along the human intestinal tract.Drug Metab Dispos. 2007 Apr;35(4):590-4. doi: 10.1124/dmd.106.013342. Epub 2007 Jan 12. Drug Metab Dispos. 2007. PMID: 17220238
-
Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease.Int J Mol Med. 2003 Feb;11(2):175-9. Int J Mol Med. 2003. PMID: 12525873
Cited by
-
Inflammation and Organic Cation Transporters Novel (OCTNs).Biomolecules. 2024 Mar 25;14(4):392. doi: 10.3390/biom14040392. Biomolecules. 2024. PMID: 38672410 Free PMC article. Review.
-
The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling.AAPS PharmSciTech. 2024 Apr 11;25(4):86. doi: 10.1208/s12249-024-02803-z. AAPS PharmSciTech. 2024. PMID: 38605192
-
Adenosine in Intestinal Epithelial Barrier Function.Cells. 2024 Feb 23;13(5):381. doi: 10.3390/cells13050381. Cells. 2024. PMID: 38474346 Free PMC article. Review.
-
Enhancing pre-clinical research with simplified intestinal cell line models.J Tissue Eng. 2024 Mar 4;15:20417314241228949. doi: 10.1177/20417314241228949. eCollection 2024 Jan-Dec. J Tissue Eng. 2024. PMID: 38449469 Free PMC article.
-
Intestinal Membrane Function in Inflammatory Bowel Disease.Pharmaceutics. 2023 Dec 25;16(1):29. doi: 10.3390/pharmaceutics16010029. Pharmaceutics. 2023. PMID: 38258040 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous